Week in Review
Adventrx Pharmaceuticals Inc. raised $17 million in a public offering of stock and warrants.
Agios Pharmaceuticals Inc. raised $78 million in a Series C financing.
Allena Pharmaceuticals Inc. raised $15 million in a Series A round for nonsystemic oral proteins.
Athersys Inc. entered a $20 million standby equity purchase agreement with Aspire Capital Fund LLC.
Cadence Pharmaceuticals Inc. is raising $71.25 million in a public stock offering.
Suite: 1100 | Atlanta, Georgia 30346, USA
In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-770-810-3144
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Sign up for Perspectives FREE e-mail newsletter